|
Segment Reporting (Details) (USD $)
|
3 Months Ended | ||
|---|---|---|---|
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Jun. 30, 2014
|
|
| Segment Reporting Information [Line Items] | |||
| Net revenues | $ 819,000 | $ 0 | |
| Research and development expenses | 1,185,000 | 552,000 | |
| General and administrative expenses | 1,050,000 | 949,000 | |
| Operating loss | (1,416,000) | 240,000 | |
| Total assets | 6,657,000 | 6,494,000 | |
|
iBio Brazil [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Net revenues | 0 | ||
| Research and development expenses | 0 | ||
| General and administrative expenses | 21,000 | ||
| Operating loss | (21,000) | ||
| Total assets | 161,000 | ||
|
iBio [Member]
|
|||
| Segment Reporting Information [Line Items] | |||
| Net revenues | 819,000 | ||
| Research and development expenses | 1,185,000 | ||
| General and administrative expenses | 1,029,000 | ||
| Operating loss | (1,395,000) | ||
| Total assets | $ 6,496,000 | ||
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|